Carlsmed (CARL) Net Shares Issued and Repurchased (2025 - 2026)
Carlsmed's (CARL) quarterly Net Shares Issued and Repurchased came in at $123112.0 in Q1 2026, down 93.31% quarter-over-quarter from $1.8 million in Q4 2025.
Powered by 
Analysis
Carlsmed (CARL) Net Shares Issued and Repurchased (2025 - 2026) Analysis & Trends
Carlsmed (CARL) has reported Net Shares Issued and Repurchased for 2 consecutive years, with $123112.0 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Net Shares Issued and Repurchased changed N/A year-over-year to $123112.0; the trailing twelve-month figure through Mar 2026 stood at $123112.0 (changed N/A YoY), and the FY2025 full-year result was $1.8 million, changed N/A from the prior year.
- Net Shares Issued and Repurchased slipped to $123112.0 in Q1 2026 per CARL's latest filing, from $1.8 million in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $1.8 million in Q4 2025 and bottomed at $123112.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | - |
| 10 | Carlsmed | 424.72 Mn | 311.42 Mn | 14.54 Mn | - |